Pineal yolk sac tumor

Jump to navigation Jump to search

WikiDoc Resources for Pineal yolk sac tumor

Articles

Most recent articles on Pineal yolk sac tumor

Most cited articles on Pineal yolk sac tumor

Review articles on Pineal yolk sac tumor

Articles on Pineal yolk sac tumor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pineal yolk sac tumor

Images of Pineal yolk sac tumor

Photos of Pineal yolk sac tumor

Podcasts & MP3s on Pineal yolk sac tumor

Videos on Pineal yolk sac tumor

Evidence Based Medicine

Cochrane Collaboration on Pineal yolk sac tumor

Bandolier on Pineal yolk sac tumor

TRIP on Pineal yolk sac tumor

Clinical Trials

Ongoing Trials on Pineal yolk sac tumor at Clinical Trials.gov

Trial results on Pineal yolk sac tumor

Clinical Trials on Pineal yolk sac tumor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pineal yolk sac tumor

NICE Guidance on Pineal yolk sac tumor

NHS PRODIGY Guidance

FDA on Pineal yolk sac tumor

CDC on Pineal yolk sac tumor

Books

Books on Pineal yolk sac tumor

News

Pineal yolk sac tumor in the news

Be alerted to news on Pineal yolk sac tumor

News trends on Pineal yolk sac tumor

Commentary

Blogs on Pineal yolk sac tumor

Definitions

Definitions of Pineal yolk sac tumor

Patient Resources / Community

Patient resources on Pineal yolk sac tumor

Discussion groups on Pineal yolk sac tumor

Patient Handouts on Pineal yolk sac tumor

Directions to Hospitals Treating Pineal yolk sac tumor

Risk calculators and risk factors for Pineal yolk sac tumor

Healthcare Provider Resources

Symptoms of Pineal yolk sac tumor

Causes & Risk Factors for Pineal yolk sac tumor

Diagnostic studies for Pineal yolk sac tumor

Treatment of Pineal yolk sac tumor

Continuing Medical Education (CME)

CME Programs on Pineal yolk sac tumor

International

Pineal yolk sac tumor en Espanol

Pineal yolk sac tumor en Francais

Business

Pineal yolk sac tumor in the Marketplace

Patents on Pineal yolk sac tumor

Experimental / Informatics

List of terms related to Pineal yolk sac tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Niloofarsadaat Eshaghhosseiny, MD[2]Sujit Routray, M.D. [3]

Synonyms and keywords: Pineal yolk sac tumors; Pineal yolk sac tumour; Pineal yolk sac tumours; Pineal endodermal sinus tumor; Pineal endodermal sinus tumors; Pineal endodermal sinus tumour; Pineal endodermal sinus tumours; Pineal yolk sac carcinoma; Pineal yolk sac carcinomas; Pineal gland tumor; Germ cell tumor; Brain tumor

Overview

Historical Perspective

  • Tumors of brainstaim as well as pineal gland,were unoperable until late of 20th century.[1]
  • Dr Cushing reported one of the first case in 1904.[1]
  • Dr Horsley in 1905 was the first who did direct surgical intervention,and in 1913 Dr Oppenhein and Krause resected pineal tumor sucssesfully.[1]
  • There are only two case Reports of pineal yolk sac tumor that are associated with Down's syndrome in English literature.[2]

Classification

Adapted from WHO:

TUMOR FREQUENCY ORIGIN
GERMCELL TOMURS 60% Rest of germ cells
Germinoma MATURE TERATOMAMATURE TERATOMATERATOMA with Malignant Transformstion Yolk sac tomur

(endodermal sinus tumor) Embryonal carcinoma Choriocarcinoma

PINEAL PARANCHIMAL TUMORS 30% pineal glandular tissue
pineocytoma (WHO grade 1) pineal paranchymal tomur of intermediate diffrentiation(WHO grade 2 or 3)

pineoblastoma(WHO grade 4) papillary tumor of pineal region

TOMURS OF SUPPORTIVE AND ADJUCENT STRUCTURES 10%
ASTROCYTOMAGlioma (glioblastoma or oligodendroglioma)Medulloepithelioma Glial cells
Ependymomachoroid plexus papilloma Ependymal lining
MENINGIOMA Arachnoid cells
HemangiomaHemangiopericytoma or

blastomaChemodectomaCraniopharyngioma

vascular cells
NON-NEOPLASTIC TUMOR LIKE CONDITIONS < 1%
Arachnoid cysts Arachnoid cells
Degenerative cysts(pineal cysts) Glial cells
Cysticercosis parasites
Arteriovenous malformations vascularization
Cavernomas Aneurysms of the vein Galen
METASTASES <.,1% Absence of blood -

brain barrier

Lung (most common),breast,stomach,kidney,melanoma

Pathophysiology

Causes

  • The intracranial GCTs are resulting of many mutations of MAPK/PI3K/mTOR pathway.[5]

Differentiating Intercranial Germ cell Tumors from Other Diseases

  • Intercranial germcell tumors must be differentiated from other diseases that cause compressive syndrome ,rise of intercranial pressure , such as other brain tumors and every disease who can rise ICP.[6]
  • Extra gonadal Germ cell tumors should be in differential diagnosis of pineal germ cell tumors.[7]

Epidemiology and Demographics

  • The incidence of pineal tumor is approximately [1%] of all intercranial tumors.[3]
  • The incidence of pineal tumor is 0,06 -0,07 per 100,000 persons per year.[3]
  • Patients of all age groups may develop pineal yolk sac tumor,But is more common in children(3-8%)and also in Japenes population.[3]
  • There is no racial predilection to pineal tumors.[3]
  • pineal tumors affect men more than women.[8]
  • The majority of pineal tumor cases are reported in Japenes population.[3]

Risk Factors

  • There are no established risk factors for pineal yolk sac tumor.

Screening

  • There is insufficient evidence to recommend routine screening for pineal yolk sac tumors.

=Natural History, Complications, and Prognosis

  • The 5 year survival rate of patients with intracranial germ cell tumors is approximately 80%.[9]
  • We can classified intercranial germ cell tumors to three main groups; good,intermediate and bad.[10]
  • pineal yolk sac tumor is in the poor prognosis classification.[10]
  • Factors that make poor prognosis is ;female ,age greater than 18,non germinoma GCTs.[9]

Diagnosis

Diagnostic Study of Choice

  • In 54% of cases diagnosis is delayed because of non-specific symptoms.[9]
  • The diagnosis of cranial germ cell tumors is based on the CT,MRI with gadolinium fundings and level of biomarkers(HCG,AFP)of serum and csf.also histology need for diffrentiate type of GCTs.With normal biomarkers level ,for definitive diagnosis biopsy is requiered.[9]
  • In addition we should determine Immunohistochemichal markers for diagnosis(c-kit/CD117,oct3/4,PLAP).[9]

=History and Symptoms


Physical Examination

  • Common physical examination findings of intracranial GTCs include papillary edema,gate disturbance,

facial nerve parasia.[6]

Laboratory Findings

  • An elevated concentration of serum/CSF HCG,AFP is diagnostic of Germ cell tumors.[6]

Electrocardiogram

  • There are no ECG findings associated with intercranial GCTs.

X-ray

  • There are no x-ray findings associated with pineal yolk sac tumors.

Echocardiography or Ultrasound

CT scan

  • Brain CT scan may be helpful in the diagnosis of intracranial Germ cell tumors. Findings on CT scan suggestive of cranial yolk sac tumors include irregular mass,may have multi cysts, and solid component has calcifications,also in plain CT is iso-low density mass with heterogenous enhancement.[11]

.

=MRI

  • Brain MRIT2-based may be helpful in the diagnosis of cranial germ celltumors. Findings on MRI T2 based diagnostic of intercranial GCTs include hyperintense to normal paranchyma.[12]

Other Imaging Findings

  • There are no other imaging findings associated with cranial GCTs.


=Other Diagnostic Studies

  • Immunohistochemichal markers and histological features may be helpful in the diagnosis of cranial GCTs. Findings suggestive of yolk sac tumor include reticular /microcytic,psudopapillary/endodermal sinus,glandular and solid patterns.[4]

Treatment

Management Options of Penial Gland tumors
CSF diversion
  • The optimal surgical strategy to treat acute hydrocephalus in patients with pineal tumors is uncertain.
  • When CSF diversion is necessary, endoscopic third ventriculostomy can be carried out at the same time as the biopsy and is preferred over VP shunts, which can be complicated by infection, shunt malfunction, subdural hematoma, and rarely, tumor seeding
Surgical resection
  • Some series report long-term survival with surgery alone, even in patients with pineoblastomas.
  • Indeed, for pineoblastomas, gross total surgical resection appears to correlate with improved survival.
  • Patients with symptomatic recurrent pineocytomas should also be considered for surgical resection of the lesion
Radiation
  • Postoperative adjuvant RT is frequently (but not universally) recommended, and local control is dose-dependent.
  • The incidence of leptomeningeal recurrence was significantly lower among patients receiving CSI compared with those who did not.
  • The five-year survival rates were 86 and 49 percent for pineocytomas and non-pineocytoma PPTs, respectively.
  • Adjuvant RT is not universally recommended after gross total resection of a pineocytoma
Stereotactic radiosurgery
  • Stereotactic radiosurgery (SRS) is emerging as a useful treatment alternative for pineocytomas, although experience is limited.
  • The precise radiation fields that are defined by MRI or CT-computerized treatment planning minimize damage to the surrounding brain, and the risks of general anesthesia and craniotomy are avoided.
  • SRS is increasingly being used to treat pineal region tumors, either as an additional therapy after conventional treatments or as a primary treatment.
  • Due to the low rate of side effects, IRS may develop into an attractive alternative to microsurgery in de novo diagnosed pineocytomas. In malignant PPTs, IRS may be routinely applied in a multimodality treatment schedule supplementary to conventional irradiation.
Chemotherapy as part of multimodality therapy
  • The similarity of pineoblastomas to medulloblastomas in terms of their clinical behavior and tendency for leptomeningeal seeding has led to the use of similar chemotherapy regimens in patients with pineoblastoma as part of a multimodality approach.
  • Chemotherapy has been used to delay radiation therapy in very young children, for whom the long-term neurocognitive and developmental side effects of craniospinal irradiation (CSI) are a major concern.
  • The importance of radiation therapy as a component of the initial treatment of supratentorial primitive neuroectodermal tumors (PNETs) is also supported by the German HIT-SKK87 and HIT-SKK92 protocols, as well as the Canadian pediatric brain tumor protocol

References

  1. 1.0 1.1 1.2 Shahinian H, Ra Y (2013). "Fully endoscopic resection of pineal region tumors". J Neurol Surg B Skull Base. 74 (3): 114–7. doi:10.1055/s-0033-1338165. PMC 3712663. PMID 24436899.
  2. Tan HW, Ty A, Goh SG, Wong MC, Hong A, Chuah KL (2004). "Pineal yolk sac tumour with a solid pattern: a case report in a Chinese adult man with Down's syndrome". J Clin Pathol. 57 (8): 882–4. doi:10.1136/jcp.2004.016659. PMC 1770394. PMID 15280413.
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Ji J, Gu C, Zhang M, Zhang H, Wang H, Qu Y; et al. (2019). "Pineal region metastasis with intraventricular seeding: A case report and literature review". Medicine (Baltimore). 98 (34): e16652. doi:10.1097/MD.0000000000016652. PMC 6716749 Check |pmc= value (help). PMID 31441839.
  4. 4.0 4.1 4.2 4.3 Ronchi A, Cozzolino I, Montella M, Panarese I, Zito Marino F, Rossetti S; et al. (2019). "Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features". Cancer Med. doi:10.1002/cam4.2195. PMID 31568647.
  5. Takami H, Fukuoka K, Fukushima S, Nakamura T, Mukasa A, Saito N; et al. (2019). "Integrated Clinical, Histopathological, and Molecular Data Analysis of 190 Central Nervous System Germ Cell Tumors from the iGCT Consortium". Neuro Oncol. doi:10.1093/neuonc/noz139. PMID 31420671.
  6. 6.0 6.1 6.2 6.3 Fang AS, Meyers SP (2013). "Magnetic resonance imaging of pineal region tumours". Insights Imaging. 4 (3): 369–82. doi:10.1007/s13244-013-0248-6. PMC 3675249. PMID 23640020.
  7. Mufti ST, Jamal A (2012). "Primary intracranial germ cell tumors". Asian J Neurosurg. 7 (4): 197–202. doi:10.4103/1793-5482.106652. PMC 3613642. PMID 23559987.
  8. Al-Hussaini M, Sultan I, Abuirmileh N, Jaradat I, Qaddoumi I (2009). "Pineal gland tumors: experience from the SEER database". J Neurooncol. 94 (3): 351–8. doi:10.1007/s11060-009-9881-9. PMC 2804886. PMID 19373436.
  9. 9.0 9.1 9.2 9.3 9.4 9.5 Fetcko K, Dey M (2018). "Primary Central Nervous System Germ Cell Tumors: A Review and Update". Med Res Arch. 6 (3). doi:10.18103/mra.v6i3.1719. PMC 6157918. PMID 30271875.
  10. 10.0 10.1 Uda H, Uda T, Nakajo K, Tanoue Y, Okuno T, Koh S; et al. (2019). "Adult-Onset Mixed Germ Cell Tumor Composed Mainly of Yolk Sac Tumor Around the Pineal Gland: A Case Report and Review of the Literature". World Neurosurg. 132: 87–92. doi:10.1016/j.wneu.2019.08.079. PMID 31470154.
  11. Fujimaki T, Matsutani M, Funada N, Kirino T, Takakura K, Nakamura O; et al. (1994). "CT and MRI features of intracranial germ cell tumors". J Neurooncol. 19 (3): 217–26. doi:10.1007/bf01053275. PMID 7807172.
  12. Morana G, Alves CA, Tortora D, Finlay JL, Severino M, Nozza P; et al. (2018). "T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study". Neuroradiology. 60 (1): 89–99. doi:10.1007/s00234-017-1947-3. PMID 29128947.
  13. Davaus T, Gasparetto EL, Carvalho Neto Ad, Jung JE, Bleggi-Torres LF (2007). "Pineal yolk sac tumor: correlation between neuroimaging and pathological findings". Arq Neuropsiquiatr. 65 (2A): 283–5. PMID 17607429.


Template:WikiDoc Sources